Empowering workplace allies for lesbian, gay, bisexual, and transgender employees to prevent and minimize psychological distress: A scoping review
Cochrane Evidence Synthesis and Methods · 2023-06 · 1 (4)
DOI: 10.1002/cesm.12018 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cochrane Evidence Synthesis and Methods, online erschienen am 23.06.2023. Verfasst von Laurie Long Kwan Ho und 5 weiteren Autor:innen. Beteiligte Einrichtung: The Nethersole School of Nursing, Faculty of Medicine The Chinese University of Hong Kong Hong Kong Hong Kong SAR. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust.
Abstract (Originalsprache)
Introduction
Lesbian, gay, bisexual, and transgender (LGBT) employees have increasingly reported experiencing different forms of workplace discrimination/harassment. Workplace allyship may be positively associated with psychological health through creating inclusive organizational cultures or reducing discrimination/harassment. However, comprehensive literature reviews or evidence syntheses on the effects of workplace allyship in mental health protection/promotion for LGBT employees are limited.
Methods
This scoping review aimed to summarize available evidence regarding the effectiveness of workplace allies for LGBT employees in preventing/minimizing psychological distress and clarify the therapeutic components. This review included published research articles and grey literature identified through 11 electronic databases, a secondary search, and other sources.
Results
We identified 27 relevant articles. Most included studies used cross‐sectional or qualitative research designs, and evidence from countries beyond the United States was limited. Three essential/effective components of workplace allies/allyship were identified that could create supportive/safe workplace relationships/climates: (a) knowledge, (b) empathy, and (c) action.
Conclusions
Further longitudinal studies and controlled trials are needed to increase the quality of evidence on the effects and change processes induced by workplace allyship. Qualitative studies are also recommended to understand the health needs and mechanism of actions of workplace allyships in different LGBT communities.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The Nethersole School of Nursing, Faculty of Medicine The Chinese University of Hong Kong Hong Kong Hong Kong SAR.
- Department of Urban Studies and Planning University of Sheffield Sheffield UK.
- The Jockey Club School of Public Health and Primary Care, Faculty of Medicine The Chinese University of Hong Kong Hong Kong Hong Kong SAR.
- Alice Lee Centre for Nursing Studies, Yong Loo Lin School of Medicine National University of Singapore Singapore Singapore.
ORCID-Profile: Laurie Long Kwan Ho, Ankie Tan Cheung, Carlo Chak Yiu Chan, Eliza Lai Yi Wong, Wilson Wai San Tam, Wai Tong Chien
Förderung
- Wellcome Trust
Zitieren
APA
Ho, L. L. K., Cheung, A. T., Chan, C. C. Y., Wong, E. L. Y., Tam, W. W. S., & Chien, W. T. (2023). Empowering workplace allies for lesbian, gay, bisexual, and transgender employees to prevent and minimize psychological distress: A scoping review. Cochrane Evidence Synthesis and Methods, 1(4). https://doi.org/10.1002/cesm.12018
Vancouver
Ho LLK, Cheung AT, Chan CCY, Wong ELY, Tam WWS, Chien WT. Empowering workplace allies for lesbian, gay, bisexual, and transgender employees to prevent and minimize psychological distress: A scoping review. Cochrane Evidence Synthesis and Methods. 2023;1(4). doi:10.1002/cesm.12018
BibTeX
@article{Ho2023,
author = {Ho, Laurie Long Kwan and Cheung, Ankie Tan and Chan, Carlo Chak Yiu and Wong, Eliza Lai Yi and Tam, Wilson Wai San and Chien, Wai Tong},
title = {Empowering workplace allies for lesbian, gay, bisexual, and transgender employees to prevent and minimize psychological distress: A scoping review},
journal = {Cochrane Evidence Synthesis and Methods},
year = {2023},
volume = {1},
number = {4},
doi = {10.1002/cesm.12018}
}
EUVIMED